Mega Lifesciences PCL (BKK:MEGA)
37.25
-0.25 (-0.67%)
Jul 24, 2026, 4:35 PM ICT
Mega Lifesciences PCL Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Mega Lifesciences PCL stock has a consensus rating of "Buy" and an average price target of ฿41.14. The average 1-year stock price forecast is 10.44% higher than the current stock price, while the lowest is ฿35.00 (-6.04%) and the highest is ฿45.00 (+20.81%).
Price Target: ฿41.14 (+10.44%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mega Lifesciences PCL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 0 | 0 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 7 | 7 | 7 |
Financial Forecast
Revenue This Year
14.91B
from 14.19B
Increased by 5.07%
Revenue Next Year
15.69B
from 14.91B
Increased by 5.19%
EPS This Year
2.68
from 2.34
Increased by 14.32%
EPS Next Year
2.87
from 2.68
Increased by 7.29%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.